DBT announces Khorana Program for Scholars

2018-01-07 02:09:59

The Khorana Program will provide opportunities to Indian students to undertake research at University of Wisconsin-Madison (UW)By Team ABLEThe Department of Biotechnology (DBT), Govt. of India, Indo-US Science and Technology Forum (IUSSTF) and WINStep Forward are partnering to support the prestigious Khorana Program for Scholars named in honor of Dr. Har Gobind Khorana, who won the Nobel Prize in

Read more

Microsoft, Google support DNAnexus with $58 million investment to accelerate expansion

2018-01-04 10:03:40

Investment led by Foresite Capital with strategic investment by Microsoft will support expansion in translational informatics, clinical trials, and broadened use of biomedical dataBy Team ABLEUS-based biomedical informatics and data management company DNAnexus has announced closing a $58 million financing led by new investor Foresite Capital with strategic investment from Microsoft. Existing inves

Read more

US FDA Commissioner Scott Gottlieb releases statement on new steps to facilitate efficient generic drug review

2018-01-04 10:00:25

FDA expects to take additional steps this year to promote competition; to help reduce drug prices and improve access to medicine for Americans.By Team ABLEThe FDA has announced, on Jan 3, 2018, additional steps to encourage generic competition as part of its continued implementation of the Drug Competition Action Plan. This plan has three main components: reducing gaming by branded companies that

Read more

Hetero launches AbbVie’s Humira biosimilar Adalimumab

2018-01-04 09:52:11

Mabura is an anti-inflammatory biologic medication specific for human tumor necrosis factor (TNF), indicated for the treatment of rheumatoid arthritis and other auto-immune disorders By Team ABLEHyderabad-based generic pharmaceutical company, Hetero Labs Ltd has announced on Jan 3, 2018 that it has launched its fourth biosimilar drug ‘Adalimumab’ under the brand name ‘Mabura’ in India. Het

Read more

Bharat Biotech’s typhoid vaccine Typbar gets WHO pre-qualification

2018-01-03 20:23:58

The $1.5 per dose ( Rs 100) is a game changer and is used in Pakistan. Global orders may get it at subsidized rates By Team ABLEIn a another major achievement, Typbar TCV, the typhoid conjugate vaccine from Krishna Ella-led Bharat Biotech has received prequalification approval from the World Health Organization (WHO) paving the way for large scale purchases by international agencies.Typbar TCV®&n

Read more

FDA approves Mylan’s generic for Estrace vaginal cream

2018-01-03 20:09:39

The US drug regulator has approved the first generic version of Allergan’s vaginal cream, Estrace, developed by Mylan on December 29,2017. Mylan received the final approval for its Abbreviated New Drug Application (ANDA) from the Food and Drug Administration(FDA) last week for its generic version, Estradiol Vaginal Cream.The innovator drug, Estrace of Allergan, had annual sales of about $387 mil

Read more

BiondVax Universal Flu Vaccine patent granted in India

2018-01-03 20:00:26

BiondVax Pharmaceuticals patents’ titled, ‘A Synthetic or Recombinant Influenza Multi-Epitope Polypeptide’ has been granted in India. By Team ABLEBiondVax Pharmaceuticals, Nasdaq-listed developer of M-001, the Universal Flu Vaccine candidate currently in preparation for a Phase 3 clinical trial, announced that one of its key patents titled, ‘A Synthetic or Recombinant Influenza Multi-Epito

Read more

Merck Foundation partners with India to build healthcare capacity in Africa

2018-01-03 19:58:52

Merck foundation brings Asia and Africa together for the first time at their annual conference \"Merck Africa Asia Luminary\"By Team ABLE Merck KGaA Germany launched their Merck Foundation, a non-profit company established in June 2017 at the Fourth edition of their annual \"Merck Africa Asia Luminary\" held in Cairo, Egypt. For the first time, Merck foundation brings Asia and Africa together in t

Read more

Manipur to host Indian Science Congress

2018-01-03 19:57:00

Manipur Central University, Imphal will now host the 105th Indian Science Congress from March 18 to 22, 2018.By Team ABLEFollowing the change in venue from Hyderabad, Manipur Central University, Imphal will now host the 105th Indian Science Congress from March 18 to 22, 2018.This was stated by the Union Minister of State (Independent Charge) of the Ministry of Development of North Eastern Region (

Read more

Health MoS Anupriya Patel updates Rajya Sabha on National Health Policy, 2017

2018-01-03 19:55:29

\n\n\n \n \n \n \n\n\n\n

The Minister\nof State (Health and Family Welfare), Smt Anupriya Patel has provided\nan update on the National Health Policy, 2017 in a written reply to\nthe Rajya Sabha on January 2, 2018.

\n

By Team ABLE

Read more